COVID-19 and autoimmune rheumatic diseases

Q4 Medicine Gaceta Medica de Caracas Pub Date : 2023-04-14 DOI:10.47307/gmc.2023.131.s2.6
Ayu Arifta Putri, A. Awalia, M. Rusli
{"title":"COVID-19 and autoimmune rheumatic diseases","authors":"Ayu Arifta Putri, A. Awalia, M. Rusli","doi":"10.47307/gmc.2023.131.s2.6","DOIUrl":null,"url":null,"abstract":"Background: Coronavirus disease 2019 (COVID-19) was declared a pandemic since it rapidly spread worldwide. COVID-19 has various manifestations, ranging from asymptomatic to life-threatening conditions. During the pandemic, patients with autoimmune rheumatic diseases (ARD) were included in the population at risk. In addition, the use of immunosuppressants or disease-modifying antirheumatic drugs (DMARDs) was considered to increase the susceptibility to infection. Studies have reported that COVID-19 and ARD have similarities in their clinical findings and immune responses. This study aims to understand the profile of patients with ARD infected with COVID-19 at Dr. Soetomo Hospital in 2020–2022.","PeriodicalId":35684,"journal":{"name":"Gaceta Medica de Caracas","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gaceta Medica de Caracas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47307/gmc.2023.131.s2.6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Coronavirus disease 2019 (COVID-19) was declared a pandemic since it rapidly spread worldwide. COVID-19 has various manifestations, ranging from asymptomatic to life-threatening conditions. During the pandemic, patients with autoimmune rheumatic diseases (ARD) were included in the population at risk. In addition, the use of immunosuppressants or disease-modifying antirheumatic drugs (DMARDs) was considered to increase the susceptibility to infection. Studies have reported that COVID-19 and ARD have similarities in their clinical findings and immune responses. This study aims to understand the profile of patients with ARD infected with COVID-19 at Dr. Soetomo Hospital in 2020–2022.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新冠肺炎与自身免疫性风湿性疾病
背景:2019冠状病毒病(COVID-19)在全球迅速传播,被宣布为大流行。COVID-19有多种表现,从无症状到危及生命的病症。在大流行期间,自身免疫性风湿病(ARD)患者被纳入高危人群。此外,使用免疫抑制剂或改善疾病的抗风湿药物(DMARDs)被认为会增加对感染的易感性。有研究报道,COVID-19和ARD在临床表现和免疫反应方面有相似之处。本研究旨在了解2020-2022年Dr. Soetomo医院感染COVID-19的ARD患者的概况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gaceta Medica de Caracas
Gaceta Medica de Caracas Medicine-Medicine (all)
CiteScore
0.30
自引率
0.00%
发文量
160
期刊介绍: Gaceta Médica de Caracas Órgano de la Academia Nacional de Medicina y del Congreso Venezolano de Ciencias Médicas Salud Fundada el 13 de marzo de 1893 Trimestral GMC
期刊最新文献
Anti-microbial Activities of Syzigium cumini leaves against Periodontophatic Bacteria (Porphyromonas gingivalis) Hardiness Personality and Family Support for Women’s Quality of Life with Breast Cancer Factors Related to Parents’ Intention in Vaccination of Human Papillomavirus for their Daughter Aged 11-12 Years Early Warning for Humans Regarding Contamination with Salmonella bacteria Originating from Duck Isolated fungal sinusitis of the sphenoid sinus - A case report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1